Identification of novel alternative splicing biomarkers for breast cancer with LC/MS/MS and RNA-Seq

Keyphrases

• Alternative Splicing 100%
• Breast Cancer 100%
• RNA Sequencing (RNA-seq) 100%
• Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS) 100%
• Splice Isoforms 15%
• Mass Spectrometry 15%
• Bioinformatics Workflow 15%
• Immune System 7%
• Diagnostic Biomarker 7%
• Human Genes 7%
• Transcriptional Level 7%
• Biological Samples 7%
• Exon 7%
• MS Data 7%
• Tandem Mass Spectrometry 7%
• Cancer Pathways 7%
• Next-generation Sequencing 7%
• Microarray Data 7%
• Liquid Chromatography 7%
• Protein Database 7%
• Metabolic Regulation 7%
• In Silico 7%
• Proteomics Data 7%
• Biological Pathways 7%
• Protein Isoforms 7%
• Hemostasis 7%
• Next-generation Sequencing Technology 7%
• Alternatives Analysis 7%
• RNA-seq Data 7%
• Plasma Proteomics 7%
• Metabolic Pathway Analysis 7%
• Omics Technologies 7%
• Search Algorithm 7%
• Cancer Proteome 7%
• RNA-Seq Database 7%
• Correlation Degree 7%
• Cancer Stage 7%
• Exon Skipping 7%
• Large-scale Detection 7%
• Qualitative Comparative Analysis 7%
• Database Techniques 7%
• Sample-specific 7%

Biochemistry, Genetics and Molecular Biology

• Alternative Splicing 100%
• RNA Sequencing 100%
• Tandem Mass Spectrometry 100%
• Isoform 23%
• RNA 23%
• Proteome 15%
• Next Generation Sequencing 15%
• Proteomics 15%
• Mass Spectrometry 15%
• Microarrays 7%
• Intron 7%
• Exon 7%
• Tandem Mass Spectrometry 7%
• Writing 7%
• Metabolic Regulation 7%
• Hemostasis 7%
• Liquid Chromatography 7%
• Exon Skipping 7%
• Protein Isoform 7%
• Protein Database 7%
• Immunity 7%
• Blood Plasma 7%